Regulator Probes Secretive Peptide Therapy Scams

The Medicines and Healthcare products Regulatory Agency (MHRA) is investigating UK clinics accused of illegally promoting experimental peptide therapies. These peptides, often administered via injection, are advertised with claims of anti-aging and enhanced recovery, despite a significant lack of robust scientific evidence in humans. Most supporting research involves animal or cellular studies.

Clinics are warned that making medicinal claims for such treatments makes them subject to regulation under the Human Medicines Regulations 2012. Despite this, some clinics continue to promote unregulated peptides, with websites listing benefits like cognitive enhancement and immune function boosts. After being questioned, one clinic removed such claims.

Some clinics acknowledge the limited human evidence but still market peptides, charging substantial monthly fees. They offer these products, labeled 'research only,' with purported "results durations." The MHRA is scrutinizing whether the advertised benefits constitute medicinal claims and will pursue action against non-compliant clinics.

Peptides are short amino acid chains. While some, like insulin, are naturally occurring and regulated, a boom in experimental peptides has occurred. The MHRA emphasizes that any substance presented as having disease-preventing or treating properties, or modifying physiological functions, is considered a medicine and subject to regulation. Claims for 'research purposes' are disregarded if they appear to be a tactic to evade regulations.